Pharma
Glox Therapeutics awarded £1M PACE grant to accelerate development of precision antibiotics against antimicrobial-resistant pathogens
Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae PACE provides funding and support for innovative, high value, high risk, early phase drug discovery and diagnostic projects Glasgow, UK, 20 ...
COPD management: a critical look at gaps in pharmaceutical innovation
Chronic Obstructive Pulmonary Disease (COPD) presents a major global health challenge, marked by chronic respiratory decline and frequent exacerbations. Despite advances in treatment, comprehensive management strategies remain limited, revealing significant gaps in patient care. ...
Mursla Bio’s EvoLiver surpasses current standards in liver cancer surveillance, data presented at AASLD Liver Meeting 2024
EvoLiver™ demonstrated 86% early-stage sensitivity at 88% specificity for liver cancer surveillance among cirrhotic, high-risk patients with diverse etiologies Validates clinical value of multi-omics content in organ-specific extracellular vesicles for liver cancer detection Data pres...
First ever UK-wide project launched to explore the inequality in access to psychological care within childhood brain tumour services
A pilot year-long project studying the inequality in access to psychological care within childhood brain tumour services, and the implications on access to clinical trials, has been launched by a team at the Great North Children’s Hospital in Newcastle. The project has been funded by ch...
Cleancube Multi: Guardtech Group’s shipping container facilities helping NHS Aseptic Pharmacies MOVE forward
Suffolk contamination control experts’ award-winning Cleancube Mobile Cleanrooms proving to be perfect solution for Trusts that require facility upgrades ...
100 guests including local sixth form students attend International Men's Day talks and wellbeing workshop at SBC
We were delighted to welcome over 100 guests to International Men’s Day at Stevenage Bioscience Catalyst. As part of our series of diversity and inclusion events this year, which have included International Women’s Day and PRIDE, we hosted talks, a Q&A and a wellbeing workshop to pr...
Keytruda LoE: A seismic shift for oncology?
Immune checkpoint inhibitors (ICIs) have changed the face of oncology treatment since their initial entry in the early 2010s. Driven mostly by the group of PD-1 and PD-L1 molecules, they have resulted in cumulative 2023 global revenues exceeding $45 billion USD. Within the PD-(L)1 class...
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
AstraZeneca announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the end of 2026. This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs contributing to the g...
Purpose-led collaboration in Pharma and HealthTech
Co-authored Samuel Hollis - Novartis
Practical Essentials of Sample Preparation Course | 16th - 19th December 2024
Join our 4-day virtual course scheduled for 16th - 19th December, 2024